Fentiazac in the treatment of some rheumatic disorders

Summary

A clinical evaluation of the effectiveness of fentiazac was carried out in 68 patients with various inflammatory and degenerative articular disorders and non-articular rheumatism. Patients were treated over a period ranging from 3 weeks to 3 months, the majority receiving 400 mg fentiazac daily. Four patients discontinued treatment during the first 2 weeks because of gastric intolerance. Fifty-three (83%) of the remaining 64 patients were considered to have shown a good or moderate overall response with improvements in all of the clinical parameters assessed. Relatively few side-effects were reported and those that appeared, mainly gastro-intestinal, were mild and transient in nature.

Key Words::

• Fentiazac
• Analgesics
• anti-inflammatory
• arthritis